Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2021-02-01

Clinical Trial Update: Analgesic Efficacy of Dexmedetomidine as Adjuvant to Levobupivacaine in Ultrasound-guided Erector Spinae Plan Block for Modified Radical Mastectomy [Phase 2, Phase 3]

View source ↗

Summary

Interim or ongoing trial evaluating dexmedetomidine as an adjuvant to levobupivacaine for erector spinae plane block to manage acute pain after modified radical…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)
  • levobupivacaine (levobupivacaine)

Snippet

Sponsor: South Egypt Cancer Institute | Conditions: Acute Pain | Phase 2, Phase 3 | Status: UNKNOWN